Omkar Pharmachem

Chemicals

532167 BSE

BSE: 532167 Commodity Chemicals

Price unavailable

Omkar Pharmachem (OMKARPH) share price was ₹6.57 at the 27 Oct 2026 close; market capitalisation ₹6.66 Cr; P/E (TTM) 73.00; sector Chemicals. The share price fell 76.8% over the year to 27 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue was ₹0.09 Cr, against ₹0.14 Cr a year earlier and net profit was −₹0.01 Cr, against ₹0.03 Cr a year earlier (compared with Jun 2025). Promoters held 0.03% of Omkar Pharmachem in Sep 2026, unchanged from Jun 2026.

Close 27 Oct 2026 ₹6.57 −23.17 −77.91% 1Y

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals

Market Cap

₹6.66 Cr

P/E (TTM)

EBITDA

₹20.00 L

Return on Equity

0.33%

Debt to Equity

Book Value

₹36.33

EPS (TTM)

₹0.09

52W High

₹29.74

52W Low

₹6.57

Price-based figures as of 27 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Commodities › Chemicals › Commodity Chemicals


SRF	₹2,350.00	32.22	69,660 Cr	4.55	0.21%	13.07%	14.64%	17,997 Cr	2,162 Cr
Tata Chemicals	₹604.60	—	15,403 Cr	0.73	1.84%	-7.73%	-2.69%	15,521 Cr	-1,971 Cr
Deepak Fertilisers & Petrochemicals	₹1,178.10	15.11	14,872 Cr	2.17	0.84%	9.90%	11.30%	12,189 Cr	984 Cr
Gujarat Narmada Valley Fert & Chem	₹515.20	7.30	7,570 Cr	0.83	4.12%	8.75%	10.38%	8,860 Cr	1,037 Cr
Tanfac Industries	—	103.79	7,489 Cr	10.36	0.13%	18.80%	25.38%	725 Cr	68 Cr
Gujarat Alkalies & Chemicals	₹552.75	61.14	4,060 Cr	0.78	3.20%	-0.05%	1.29%	4,622 Cr	66 Cr
GHCL	₹387.40	7.71	3,569 Cr	1.00	3.04%	13.30%	16.87%	3,138 Cr	473 Cr
Omkar Pharmachem (this company)	—	73.00	7 Cr	0.18	0.00%	0.33%	0.45%	0 Cr	0 Cr
Median 8 companies	₹578.68	32.22	7,529 Cr	0.92	1.34%	9.33%	10.84%	6,741 Cr	271 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Strengths

Company has reduced debt.
Company is almost debt free.
Stock is trading at 0.27 times its book value
Debtor days have improved from 41.6 to 23.3 days.

Weaknesses

Though the company is reporting repeated profits, it is not paying out dividend
The company has delivered a poor sales growth of 11.7% over past five years.
Promoter holding is low: 0.03%
Company has a low return on equity of 1.23% over last 3 years.

Technical Indicators

Oscillators

Bullish

Bearish

Neutral

Bullish

Overall

Bearish

Neutral

Bullish

Moving Averages

Bearish

Neutral

Bullish

Growth Rate

Revenue Growth

change over 1 year

Net Income Growth

-50%

change over 1 year

Cash Flow Change

-4.17%

change over 1 year

EBITDA Margin Change

-33.92%

change over 1 year Operating margin -11.11% · Jun 2026

Quarterly Results

Particulars	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	0.14	0.14	0.14	0.14	0.14	0.14	0.14	0.14	0.14	0.14	0.11	0.09	0.09
Expenses	0.09	0.05	0.07	0.06	0.09	0.05	0.05	0.07	0.1	0.07	0.07	0.07	0.1
Operating Profit	0.05	0.09	0.07	0.08	0.05	0.09	0.09	0.07	0.04	0.07	0.04	0.02	-0.01
OPM %	35.71%	64.29%	50%	57.14%	35.71%	64.29%	64.29%	50%	28.57%	50%	36.36%	22.22%	-11.11%
Other Income	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest	0	0	0	0.03	0	0	0	0.02	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0
PBT	0.05	0.09	0.07	0.05	0.05	0.09	0.09	0.05	0.04	0.07	0.04	0.02	-0.01
Tax %	0%	0%	0%	120%	0%	0%	0%	140%	25%	28.57%	25%	0%	0%
Net Profit	0.05	0.09	0.07	-0.02	0.05	0.09	0.08	-0.02	0.03	0.05	0.03	0.02	-0.01
EPS (₹)	0.05	0.09	0.07	-0.02	0.05	0.09	0.08	-0.02	0.03	0.05	0.03	0.02	-0.01

Show % Change

Figures in ₹ Crores

Profit & Loss

Particulars	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	0	0	0	0	0	0.05	0.27	0.54	0.54	0.54	0.54	0.47	0.43
Expenses	0.06	0.12	0.22	0.24	0.38	0.26	0.24	0.27	0.22	0.25	0.24	0.31	0.31
Operating Profit	-0.06	-0.12	-0.22	-0.24	-0.38	-0.21	0.03	0.27	0.32	0.29	0.3	0.16	0.12
OPM %	—	—	—	—	—	-420%	11.11%	50%	59.26%	53.7%	55.56%	34.04%	27.91%
Other Income	0	0	0.49	0	0	0	0	0	0	0	0	0.01	0
Interest	0	0	0	0.01	0.04	0.05	0.06	0.06	0.05	0.03	0.02	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0	0.01	0	0
PBT	-0.06	-0.12	0.27	-0.25	-0.42	-0.26	-0.03	0.21	0.27	0.26	0.27	0.17	0.12
Tax %	0%	0%	18.52%	0%	0%	0%	-866.67%	14.29%	25.93%	23.08%	25.93%	23.53%	—
Net Profit	-0.06	-0.12	0.22	-0.26	-0.42	-0.26	0.22	0.18	0.2	0.19	0.2	0.12	0.09
EPS (₹)	-0.06	-0.12	0.22	-0.26	-0.42	-0.26	0.22	0.18	0.2	0.19	0.2	0.12	0.09
Div. Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	—

Show % Change

Figures in ₹ Crores

Balance Sheet

Particulars	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	10.08	10.08	10.08	10.08	10.08	10.08	10.08	10.08	10.08	10.08	10.08	10.08
Reserves	-0.81	-0.93	-0.71	-0.96	-1.38	-1.64	-1.42	-1.24	-1.04	-0.85	-0.65	26.56
Borrowings	0.01	0	0	0.24	0.58	0.87	0.9	0.93	0.62	0.3	0.12	0
Other Liabilities	0.13	0.57	0.06	0.04	0.05	0.06	0.08	0.06	0.07	0.07	0.05	0.05
Total Liabilities	9.41	9.72	9.43	9.4	9.33	9.37	9.64	9.83	9.73	9.6	9.6	36.69
Fixed Assets	0.01	0.01	0	0.01	0	0	0	0.01	0	0.01	0.01	0
CWIP	0	0	0	0	0	0	0	0	0	0	0	0
Investments	9.3	9.3	9.3	9.3	9.3	9.3	9.3	9.3	9.3	9.3	9.3	36.38
Other Assets	0.1	0.41	0.13	0.09	0.03	0.07	0.34	0.52	0.43	0.29	0.29	0.31
Total Assets	9.41	9.72	9.43	9.4	9.33	9.37	9.64	9.83	9.73	9.6	9.6	36.69

Show % Change

Figures in ₹ Crores

Cash Flow

Particulars	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating	-0.05	0.34	-0.77	-0.25	-0.3	-0.21	0.02	0.2	0.28	0.3	0.24	0.23
Investing	0	0	0.49	-0.01	0	0	0	-0.01	0	-0.01	0	0
Financing	0	-0.01	0.01	0.23	0.3	0.24	-0.02	-0.03	-0.35	-0.35	-0.2	-0.12
Net Cash Flow	-0.05	0.33	-0.28	-0.03	0	0.02	0	0.17	-0.08	-0.06	0.04	0.11
Free Cash Flow	-0.05	0.34	-0.29	-0.26	-0.3	-0.21	0.02	0.19	0.28	0.29	0.24	0.23
CFO/OP	83	-283	327	104	79	100	67	74	88	103	80	150

Show % Change

Figures in ₹ Crores

Ratios

Particulars	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	—	—	—	—	—	146	40.56	54.07	87.87	33.8	67.59	23.3
Cash Conversion Cycle	—	—	—	—	—	146	40.56	54.07	87.87	33.8	67.59	23.3
Working Capital Days	—	—	—	—	—	-6,570	-1,271	-608	-379	-162	-6.76	23.3
ROCE %	-0.64%	-1.3%	-2.27%	-2.56%	-4.08%	-2.26%	0.32%	2.79%	3.29%	3.02%	3.04%	0.74%

Show % Change

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Basic EPS

▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓

Book Value per Share

▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓

Capital Expenditure

▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓

Cash & Equivalents

▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓

Cash Flow from Financing

▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓

Cash Flow from Investing

▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓

Current Ratio

▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓

Current Tax

▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓

56 extracted metrics + investor summaries across FY11–FY27.

Shareholding Pattern

Documents

Unaudited Financial Results For The Quarter Ended On 30.06.2026 13 Aug 2026

Financial Results For The Quarter And Year Ended 31.03.2026 30 May 2026

Unaudited Financial Results For The Quarter And Nine Months Ended On 31.12.2025 14 Feb 2026

Results- Unaudited Financial Results For September 2025 14 Nov 2025

Results- Financial Results For June 2025 13 Aug 2025

Frequently Asked Questions about Omkar Pharmachem

What does Omkar Pharmachem Ltd do?

Incorporated in 1995, Omkar Pharmachem Ltd provides business support services.[1]

Where is Omkar Pharmachem Ltd (OMKARPH) listed?

Omkar Pharmachem Ltd trades under code 532167 on the BSE.

Which sector does Omkar Pharmachem Ltd belong to?

Omkar Pharmachem Ltd is classified under the Chemicals sector, in the Commodity Chemicals industry.

What is the market capitalisation of Omkar Pharmachem Ltd?

Omkar Pharmachem Ltd has a market capitalisation of ₹6.66 Cr as of 27 Oct 2026, which places it in the Small Cap band.

What is the PE ratio of Omkar Pharmachem Ltd?

Omkar Pharmachem Ltd trades at a PE ratio of 73.00 as of 27 Oct 2026, on earnings per share of ₹0.09, against a book value of ₹36.33 per share.

What is the 52-week high and low of Omkar Pharmachem Ltd?

Over the last 52 weeks Omkar Pharmachem Ltd has traded between ₹6.57 and ₹29.74 as of 27 Oct 2026.

What is the Return on Equity (ROE) of Omkar Pharmachem Ltd?

Omkar Pharmachem Ltd reported a return on equity of 0.33%. Its debt-to-equity ratio is 0.00.

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/532167.md for Omkar Pharmachem Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List FII and DII flows, month by month How Tapetide Scores changed, month by month Stocks mutual funds are buying, month by month

Omkar Pharmachem

Key Fundamentals

Peer Comparison

Key Insights

Strengths

Weaknesses

Technical Indicators

Oscillators

Overall

Moving Averages

Growth Rate

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Insights

Shareholding Pattern

Documents

Frequently Asked Questions about Omkar Pharmachem

Company Information

For AI agents and developers

Explore More